1

Only Company Making Monkeypox Vaccine Not Sure If It Can Meet Demand

 1 year ago
source link: https://www.businessinsider.com/company-monkeypox-vaccine-not-sure-if-it-can-meet-demand-2022-8
Go to the source link to view the article. You can view the picture content, updated content and better typesetting reading experience. If the link is broken, please click the button below to view the snapshot at that time.
Home Chevron iconIt indicates an expandable section or menu, or sometimes previous / next navigation options. News

The only company with a vaccine approved for monkeypox says it's not sure if it can keep up with demand

2 hours ago
Save Article IconA bookmark
Share iconAn curved arrow pointing right.
men wait in line for monkeypox vaccine in new york

People wait in line to recieve the Monkeypox vaccine at a new mass vaccination site in Brooklyn on July 17, 2022, in New York City. Kena Betancur/AFP via Getty Images

  • The drugmaker of the only approved vaccine for monkeypox said its not sure if it can meet the demand.
  • "Demand keeps rising," a vice president at the Danish company that manufactures the vaccine told Bloomberg.
  • The WHO declared the growing monkeypox outbreak a global public health emergency last month.
Sign up for our newsletter to receive our top stories based on your reading preferences — delivered daily to your inbox.
Email address
By clicking ‘Sign up’, you agree to receive marketing emails from Insider as well as other partner offers and accept our Terms of Service and Privacy Policy.

The drugmaker of the world's only approved vaccine for monkeypox said that it is now not sure if it can meet demand as cases for the virus continue to rise across the globe. 

"It's a very dynamic market situation," Rolf Sass Sorensen, a vice president at Bavarian Nordic, the Danish biotechnology company that manufactures the Jynneos monkeypox vaccine, told Bloomberg in a report published on Wednesday.

"Demand keeps rising and it's no longer certain that we can continue to meet the demand we're facing even with the upgrade of our existing manufacturing site in Denmark," Sorensen said, according to the news outlet. 

He added that Bavarian Nordic is now considering partnerships for its production of the shot — a smallpox vaccine that works against monkeypox.

Sharing the technology with a manufacturer in the United States is on the table, Sorensen said. 

"We're looking at ways to get help from partners in all the various production steps of the vaccine," the vice president of investor relations told Bloomberg. 

He added, "We don't have any concrete negotiations in the works with bulk producers, but we're investigating and looking at what options there are."

Bavarian Nordic's monkeypox vaccine has been approved for use by the US, the European Union, and Canada. 

Last month, the World Health Organization declared the growing monkeypox outbreak a global public health emergency

According to the latest data by the US Centers for Disease Control and Prevention, more than 38,000 monkeypox cases have been confirmed in nearly 100 countries around the world. A dozen deaths have been caused by the virus, according to the CDC. 

The US has recorded more than 12,600 confirmed monkeypox cases, the CDC data shows. 

Monkeypox is typically transmitted through very close contact and can cause rashes or puss-filled boils that cover the body and flu-like symptoms, including fever and muscle aches.


About Joyk


Aggregate valuable and interesting links.
Joyk means Joy of geeK